Rising cases of Breast Cancer drives the Growth of Handheld Fluorescence Imaging Devices Market Unveils Fact.MR

Handheld fluorescence imaging devices are used for diagnostics patients and offer advantages over conventional testing method by delivering results in short span of time. Therefore, with the help of such devices, it is possible for caregivers and doctors to provide immediate effective treatment and diagnosis to the patient.

The application of such devices are vast in modern healthcare such as venipuncture, wound healing and many other. For instance, on August 2018, FDA cleared MolecuLight® Inc.’s, which is a first of its kind handheld fluorescence imaging devices. In addition, this device documents and captures fluorescence information from surrounding tissues and wounds using still video and images in real-time.

To remain ‘ahead’ of your competitors, request for a sample https://www.factmr.com/connectus/sample?flag=S&rep_id=5266

Presently, a number of handheld fluorescence imaging devices manufacturers are engaged in efforts to improve the quality of such devices such as device is sterilizable along with less radiation emissions that leads to less radiation exposure to the surgical staff and patients.

Handheld Fluorescence Imaging Devices Market: Drivers and Restraint

Rising cases of breast cancer and chronic diseases around the globe is the primary factor driving the growth of handheld fluorescence imaging devices market. The rising cases of the breast cancer have shifted the focus of researchers on more improved technology providing new imaging tool that improves tumor visualization during the first surgery of breast cancer, hence driving the growth of handheld fluorescence imaging devices market.

Advancements in technology and technique is another determinant of the handheld fluorescence imaging devices market as represented by the development of complex procedures along with better efficiency of the devices such as PRODIGI, is a new handheld- fluorescence imaging devices which is used to differentiate between healthy breast tissues and tumor.

Besides, these devices helps to reduce emergency room overcrowding as the diagnosis speeds up. Handheld fluorescence imaging devices are transportable and portable.

On the other hand, diagnosis with handheld fluorescence imaging devices requires less time and may affect the understanding of the results along with storage of data. Thus, this is turn, is expected to hamper the growth of handheld fluorescence imaging devices market.

Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=AE&rep_id=5266

Handheld Fluorescence Imaging Devices Market: Segmentation

The global handheld fluorescence imaging devices market is classified on the basis of Product, Compatibility, and End User.

Based on Product, Handheld Fluorescence Imaging Devices market is segmented into the following:

• With Transducer
• Without Transducer
• Accessories

Based on Compatibility, Handheld Fluorescence Imaging Devices market is segmented into the following:

• Android
• iOS

Based on End User, Handheld Fluorescence Imaging Devices market is segmented into the following:

• Hospitals
• Diagnostic Centers
• Surgical Centers
• Point of Care
• Others

Handheld Fluorescence Imaging Market: Overview

The Global handheld fluorescence imaging devices are majorly dominated by with transducer among product segment.  The rising cases of breast cancer along with huge burden of wound care to healthcare systems. This will help increase demand of handheld fluorescence imaging devices in image guided diagnostic procedure which, is cost effective and provides high quality images.

Among the compatibility, android will capture the largest revenue in handheld fluorescence imaging devices market as the handheld fluorescence imaging devices with android is easy to handle and monitor the devices properly without any disturbance.

Moreover, the handheld fluorescence imaging devices with android provides better colour contrast, making it diagnostic procedure more efficient. Hospitals generate largest revenue share in handheld fluorescence imaging devices market as the hospitals use advanced technology for patient care that also reduces cost by reducing hospital visits.

Handheld Fluorescence Imaging: Impact of COVID 19

COVID-19 which, originated in the city of Wuhan, Mainland China, has spread aggressively to evolve into a global pandemic involving more than 170 countries. This pandemic has affected lives across the  economic, social and political sphere. Treating COVID 19 infected patients is the primary focus of doctors and physicians alike at the moment, as this infection has no available cure.

A breakthrough at this moment can decrease the stock prices of handheld fluorescence imaging devices manufacturers due to decrease patient pool thereby hampering the growth of handheld fluorescence imaging devices procedures.

Pre-Book Right Now for Exclusive Analyst Support – https://www.factmr.com/checkout/5266/S

Handheld Fluorescence Imaging Market: Regional Overview

North America will show the high revenue for the handheld fluorescence imaging devices market since, the prevalence of breast cancer is more and also by rapid adoption of handheld fluorescence imaging devices in diagnostic procedures specially during wound care treatment.

For instance, in December 2019, Smith & Nephew, Inc. received the U.S FDA approval for i: X handheld fluorescence imaging device for detection of wound management and bacteria. After North America, the Europe region will show the robust growth for handheld fluorescence imaging devices market in the near future, due to availability of better hospital infrastructure in European countries.

Latin America region will show the significant demand for the handheld fluorescence imaging devices market, due to the regional government funding towards research and development for enhancing imaging techniques. The Middle East and Africa are expected to be least lucrative region for handheld fluorescence imaging devices market due to a smaller number of hospitals infrastructure.

Handheld Fluorescence Imaging Market: Key Players

Examples of some of the market participants in handheld fluorescence imaging devices market are Smith & Nephew, Inc, Kent Imaging INC., General Electric Company, BLZ Technology Inc., Healcerion, Inc., Butterfly Network, Inc., Hunan Ramzed Medical Imaging Technology Co., Ltd., Koninklijke Philips N.V., Siemens and others

The research report on handheld fluorescence imaging devices market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on handheld fluorescence imaging devices market provides analysis and information according to market segments such as geographies, product, and industry.

The report covers exhaust analysis on Handheld Fluorescence Imaging Market:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Report on Handheld Fluorescence Imaging Market includes regional analysis:

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Europe (Germany, Italy, France, U.K, Spain, Russia)
• East Asia (China, Japan, South Korea)
• South Asia (India, ASEAN)
• Oceania (Australia, New Zealand)
• Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report on handheld fluorescence imaging market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact: